Impact BioMedical Inc.
IBO
$0.45
-$0.0225-4.76%
AMEX
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.32M | 2.00M | 2.67M | 2.00K | 2.00K |
Total Receivables | 204.00K | 184.00K | 142.00K | 263.00K | 331.00K |
Inventory | 489.00K | -- | -- | -- | -- |
Prepaid Expenses | 172.00K | 265.00K | 365.00K | 42.00K | 2.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 2.18M | 2.45M | 3.18M | 307.00K | 335.00K |
|
|||||
Total Current Assets | 2.18M | 2.45M | 3.18M | 307.00K | 335.00K |
Net Property, Plant & Equipment | 16.00K | 17.00K | 282.00K | 284.00K | 285.00K |
Long-term Investments | -- | -- | 25.09M | 25.09M | 25.09M |
Goodwill | -- | -- | 25.09M | 25.09M | 25.09M |
Total Other Intangibles | 17.85M | 17.81M | 18.09M | 18.37M | 18.64M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | 17.00K | 59.00K | 67.00K | -- |
Total Assets | 20.05M | 20.29M | 46.70M | 44.12M | 44.36M |
|
|||||
Total Accounts Payable | 615.00K | 713.00K | 1.00M | 986.00K | 1.02M |
Total Accrued Expenses | 217.00K | 194.00K | 102.00K | 61.00K | 47.00K |
Short-term Debt | 9.14M | 8.84M | -- | 13.45M | 12.79M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | 35.00K | 35.00K | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 9.97M | 9.79M | 1.14M | 14.50M | 13.86M |
|
|||||
Total Current Liabilities | 9.97M | 9.79M | 1.14M | 14.50M | 13.86M |
Long-Term Debt | -- | -- | 7.97M | -- | -- |
Short-term Debt | 9.14M | 8.84M | -- | 13.45M | 12.79M |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 3.27M | 3.27M | 3.24M | 3.24M | 3.24M |
Total Liabilities | 13.24M | 13.05M | 12.34M | 17.73M | 17.09M |
|
|||||
Common Stock & APIC | 42.72M | 41.87M | 41.85M | 38.12M | 38.12M |
Retained Earnings | -38.94M | -37.67M | -10.56M | -14.81M | -13.92M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 3.78M | 4.20M | 31.29M | 23.31M | 24.20M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 60.00K | 60.00K | 60.00K | 60.00K | 60.00K |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 60.00K | 60.00K | 60.00K | 60.00K | 60.00K |
|
|||||
Total Common Equity | 3.78M | 4.20M | 31.29M | 23.31M | 24.20M |
Total Preferred Equity | 60.00K | 60.00K | 60.00K | 60.00K | 60.00K |
Total Minority Interest | 2.97M | 2.98M | 3.00M | 3.01M | 3.00M |
Total Equity | 6.81M | 7.24M | 34.35M | 26.38M | 27.26M |
|